Literature DB >> 1744124

Differential expression of small chondroitin/dermatan sulfate proteoglycans, PG-I/biglycan and PG-II/decorin, by vascular smooth muscle and endothelial cells in culture.

H T Järveläinen1, M G Kinsella, T N Wight, L J Sandell.   

Abstract

Cultured bovine aortic smooth muscle (BASM) and endothelial (BAE) cells, like articular chondrocytes, synthesize two populations of small chondroitin/dermatan sulfate (CS/DS) proteoglycans (PGs) of similar size as PG-I/biglycan and PG-II/decorin. However, Northern blot analyses demonstrated that BAE cells express detectable amounts of mRNA transcripts only for PG-I/biglycan, whereas BASM cells and articular chondrocytes express mRNA transcripts for both PG-I/biglycan and PG-II/decorin. Endothelial cells from human umbilical vein also expressed detectable amounts of mRNA transcripts only for PG-I/biglycan, and not PG-II/decorin. Antiserum raised against bovine PG-II/decorin immunoprecipitated an apparent single PG species with relative molecular mass (Mr) of approximately 120,000-180,000 from BASM cell and articular chondrocyte cultures but failed to immunoprecipitate an equivalent PG species from BAE cell cultures, consistent with the results from Northern blot analysis. In contrast, immunoprecipitations by antisera to PG-I/biglycan indicated that cultured endothelial cells synthesize two forms of PG-I/biglycan with Mr values slightly larger than 200,000 and 120,000-140,000. It is likely, based on the magnitude of the size difference, that these two forms of PG-I/biglycan differ in the number of glycosaminoglycan chains. Additionally, BASM but not BAE cells were found to express detectable amounts of mRNA transcripts for type I collagen. The above results indicate that the two main cell types of the vascular wall, endothelial and smooth muscle cells, express different sets of small interstitial CS/DS PGs and that the synthesis of PG-II/decorin by these cells correlates with the expression of type I collagen, a collagen known to interact specifically with this PG. These differences in the expression of extracellular matrix molecules may be important in regulating the cell type-specific functions of endothelial and smooth muscle cells within the vascular tissue.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1744124

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

1.  Decorin is produced by capillary endothelial cells in inflammation-associated angiogenesis.

Authors:  L Nelimarkka; H Salminen; T Kuopio; S Nikkari; T Ekfors; J Laine; L Pelliniemi; H Järveläinen
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

2.  Differential availability/processing of decorin precursor in arterial and venous smooth muscle cells.

Authors:  Rafaella Franch; Angela Chiavegato; Maddalena Maraschin; Serena Candeo; Simonetta Ausoni; Antonello Villa; Gino Gerosa; Lisa Gasparotto; Pierpaolo Parnigotto; Saverio Sartore
Journal:  J Anat       Date:  2006-09       Impact factor: 2.610

Review 3.  Pivotal role for decorin in angiogenesis.

Authors:  Hannu Järveläinen; Annele Sainio; Thomas N Wight
Journal:  Matrix Biol       Date:  2015-02-07       Impact factor: 11.583

4.  A finite dissipative theory of temporary interfibrillar bridges in the extracellular matrix of ligaments and tendons.

Authors:  P Ciarletta; M Ben Amar
Journal:  J R Soc Interface       Date:  2008-12-23       Impact factor: 4.118

5.  Effect of hyperglycemic condition on proteoglycan secretion in cultured human endothelial cells.

Authors:  Sedegheh Gharagozlian; Jørgen Borrebaek; Tore Henriksen; Tone Kristin Omsland; Hamid Shegarfi; Svein Olav Kolset
Journal:  Eur J Nutr       Date:  2006-06-29       Impact factor: 5.614

6.  Perlecan regulates Oct-1 gene expression in vascular smooth muscle cells.

Authors:  M C Weiser; N A Grieshaber; P E Schwartz; R A Majack
Journal:  Mol Biol Cell       Date:  1997-06       Impact factor: 4.138

7.  Thiazolidinediones reduce the LDL binding affinity of non-human primate vascular cell proteoglycans.

Authors:  L R Tannock; P J Little; C Tsoi; P H R Barrett; T N Wight; A Chait
Journal:  Diabetologia       Date:  2004-04-08       Impact factor: 10.122

8.  Retrovirally mediated overexpression of glycosaminoglycan-deficient biglycan in arterial smooth muscle cells induces tropoelastin synthesis and elastic fiber formation in vitro and in neointimae after vascular injury.

Authors:  Jin-Yong Hwang; Pamela Y Johnson; Kathleen R Braun; Aleksander Hinek; Jens W Fischer; Kevin D O'Brien; Barry Starcher; Alexander W Clowes; Mervyn J Merrilees; Thomas N Wight
Journal:  Am J Pathol       Date:  2008-11-06       Impact factor: 4.307

9.  Identification of SOX9 interaction sites in the genome of chondrocytes.

Authors:  Chun-do Oh; Sankar N Maity; Jing-Fang Lu; Jiexin Zhang; Shoudan Liang; Francoise Coustry; Benoit de Crombrugghe; Hideyo Yasuda
Journal:  PLoS One       Date:  2010-04-09       Impact factor: 3.240

10.  Regional differences in the distribution of the proteoglycans biglycan and decorin in the extracellular matrix of atherosclerotic and restenotic human coronary arteries.

Authors:  R Riessen; J M Isner; E Blessing; C Loushin; S Nikol; T N Wight
Journal:  Am J Pathol       Date:  1994-05       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.